Last reviewed · How we verify

NCT06151054: RAIPAo

Relationship Between Aortic Parietal Inflammation on 18F-FDG PET Scan and Arterial Stiffness as a Function of Age

Completed Last updated 30 November 2023
What this trial tests

trial testing Measure of aortic inflammation in Arterial Stiffness in 89 participants. Completed in 6 December 2022.

Timeline
30 October 2022
Primary endpoint
30 November 2022
6 December 2022

Quick facts

Lead sponsorCentral Hospital, Nancy, France
StatusCompleted
Study typeOBSERVATIONAL
Enrollment89
Start date30 October 2022
Primary completion30 November 2022
Estimated completion6 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 18 to 95, any sex, with Arterial Stiffness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Show that there is a relationship between arterial stiffness and aortic parietal inflammation and that this relationship is different in the three age groups with aortic parietal inflammation occurring earlier than arterial stiffness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Arterial Stiffness

Currently open trials in the same condition.

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06151054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing